BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9510174)

  • 1. CD4+, but not CD8+, T cells from mammary tumor-bearing mice have a down-regulated production of IFN-gamma: role of phosphatidyl serine.
    Cheng X; Lopez DM
    J Immunol; 1998 Mar; 160(6):2735-41. PubMed ID: 9510174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-gamma production in mammary tumor-bearing mice.
    Handel-Fernandez ME; Cheng X; Herbert LM; Lopez DM
    J Immunol; 1997 Jan; 158(1):280-6. PubMed ID: 8977200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
    Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
    Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.
    Calderon CL; Torroella-Kouri M; Dinapoli MR; Lopez DM
    Int J Oncol; 2008 Mar; 32(3):713-21. PubMed ID: 18292949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells.
    Kolls JK; Habetz S; Shean MK; Vazquez C; Brown JA; Lei D; Schwarzenberger P; Ye P; Nelson S; Summer WR; Shellito JE
    J Immunol; 1999 Mar; 162(5):2890-4. PubMed ID: 10072538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Con A-dependent cytokine production from CD4+ and CD8+ T lymphocytes by autosecretion of histamine.
    Sonobe Y; Nakane H; Watanabe T; Nakano K
    Inflamm Res; 2004 Mar; 53(3):87-92. PubMed ID: 15021962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors.
    Owen JL; Lopez DM; Grosso JF; Guthrie KM; Herbert LM; Torroella-Kouri M; Iragavarapu-Charyulu V
    Cell Immunol; 2005 Jun; 235(2):122-35. PubMed ID: 16243300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
    Fu Y; Paul RD; Wang Y; Lopez DM
    J Immunol; 1989 Dec; 143(12):4300-7. PubMed ID: 2592775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
    Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A
    Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine colostral CD8-positive cells are potent IFN-gamma-producing cells.
    Hagiwara K; Domi M; Ando J
    Vet Immunol Immunopathol; 2008 Jul; 124(1-2):93-8. PubMed ID: 18400306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
    Elsässer-Beile U; Rindsfüser M; Grussenmeyer T; Schultze-Seemann W; Wetterauer U
    Br J Cancer; 2000 Sep; 83(5):637-41. PubMed ID: 10944605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
    Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
    J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
    Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ
    J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 up-regulates T-bet independently of IFN-gamma in human CD4+ T cells.
    Ylikoski E; Lund R; Kyläniemi M; Filén S; Kilpeläinen M; Savolainen J; Lahesmaa R
    Eur J Immunol; 2005 Nov; 35(11):3297-306. PubMed ID: 16220539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both CD4(+)and CD8(+)T cells are required for IFN-gamma gene expression in pancreatic islets and autoimmune diabetes development in biobreeding rats.
    El-Sheikh A; Suarez-Pinzon WL; Power RF; Rabinovitch A
    J Autoimmun; 1999 Mar; 12(2):109-19. PubMed ID: 10047431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
    Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
    J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.